ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,467.85
      -0.99%
      US Tech 100
      18,528.80
      -1.67%
      Dow Jones
      40,349.95
      -1.21%
      Brent Oil
      80.155
      -1.66%
      Bitcoin
      62,793.80
      -2.78%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Alzamend Neuro Inc (ALZN) Quote

      Alzamend Neuro Inc

      Alzamend Neuro Inc (ALZN)

      NASDAQ
      3.53
      -0.04
      ( -1.12% )
      Updated: 11:47:56
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      3.53
      Bid
      3.52
      Ask
      3.69
      Volume
      6,065
      3.47 Day's Range 3.69
      0.3691 52 Week Range 7.20
      Market Cap
      2.818M
      Previous Close
      3.57
      Open
      3.69
      Last Trade
      1
      @
      3.54
      Last Trade Time
      11:47:25
      Financial Volume
      $ 21,637
      VWAP
      3.5675
      Average Volume (3m)
      83,570
      Shares Outstanding
      798,176
      Dividend Yield
      -
      PE Ratio
      -0.19
      Earnings Per Share (EPS)
      -18.64
      Revenue
      -
      Net Profit
      -14.88M

      About Alzamend Neuro Inc

      Alzamend Neuro Inc is an early clinical stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipe... Alzamend Neuro Inc is an early clinical stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.alzamend.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      1970
      Alzamend Neuro Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ALZN. The last closing price for Alzamend Neuro was $3.57. Over the last year, Alzamend Neuro shares have traded in a share price range of $ 0.3691 to $ 7.20.

      Alzamend Neuro currently has 798,176 shares outstanding. The market capitalization of Alzamend Neuro is $2.85 million. Alzamend Neuro has a price to earnings ratio (PE ratio) of -0.19.

      ALZN Latest News

      More News

      FeaturedPOET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks

      3 hours ago

      ECHO BOURSE: PPG avertit sur ses résultats en raison d'un ralentissement de la demande

      NEW YORK (Agefi-Dow Jones)--L'action PPG plonge de 7% lundi en préouverture à la Bourse de New York, après que le groupe de chimie de spécialité a réduit...

      October 10 2022
      Dow Jones News

      AkzoNobel delivers 15 by 20 promise and continues strong momentum in Q4, with 6% revenue growth in comparable currencies

      February 17, 2021 AkzoNobel delivers 15 by 20 promise and continues strong momentum in Q4, with 6% revenue growth in comparable currencies Akzo Nobel N.V. (AKZA; AKZOY) publishes results for...

      February 17 2021
      GlobeNewswire Inc.

      AkzoNobel confirms intent to acquire Tikkurila with binding proposal for €31.25 per share, with due diligence supporting va...

      January 28, 2021 AkzoNobel confirms intent to acquire Tikkurila with binding proposal for €31.25 per share, with due diligence supporting value creation opportunity Akzo Nobel N.V. (AKZA; AKZOY...

      January 28 2021
      GlobeNewswire Inc.

      AkzoNobel renchérit sur PPG et propose 1,4 milliard d'euros pour acquérir Tikkurila

      BARCELONE (Agefi-Dow Jones)--AkzoNobel a annoncé lundi qu'il proposait d'acquérir la société finlandaise Tikkurila pour 1,4 milliard d'euros, un montant...

      January 18 2021
      Dow Jones News

      AkzoNobel proposes to acquire Tikkurila for €31.25 per share, to create superior and sustainable value for all stakeholders...

      January 18, 2021 AkzoNobel proposes to acquire Tikkurila for €31.25 per share, to create superior and sustainable value for all stakeholders Akzo Nobel N.V. (AKZA; AKZOY) has today made a...

      January 18 2021
      GlobeNewswire Inc.

      AkzoNobel weathering COVID-19 storm

      June 11, 2020 AkzoNobel weathering COVID-19 storm As the complex situation regarding the global pandemic continues to evolve, AkzoNobel (AKZA; AKZOY) remains focused on ensuring employee health...

      June 11 2020
      GlobeNewswire Inc.

      AkzoNobel’s Q1 results show 31% profitability improvement, despite headwinds from COVID-19

      April 22, 2020 AkzoNobel’s Q1 results show 31% profitability improvement, despite headwinds from COVID-19 Akzo Nobel N.V. (AKZA; AKZOY) publishes results for first quarter 2020 Highlights Q1 2020...

      April 22 2020
      GlobeNewswire Inc.

      AkzoNobel’s Q4 and full-year 2019 results show transformation on track, with further step up in profitability, despite soft...

      February 12, 2020 AkzoNobel’s Q4 and full-year 2019 results show transformation on track, with further step up in profitability, despite softer end market demand Akzo Nobel N.V. (AKZA; AKZOY...

      February 12 2020
      GlobeNewswire Inc.

      AkzoNobel’s Q2 results show progress towards 15 by 20 strategy, with adjusted operating income up 36%, despite continued ex...

      July 24, 2019 AkzoNobel’s Q2 results show progress towards 15 by 20 strategy, with adjusted operating income up 36%, despite continued external headwinds Akzo Nobel N.V. (AKZA; AKZOY) publishes...

      July 24 2019
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.22-5.866666666673.754.253.4001409933.70734798CS
      43.127775.9305210920.4034.420.37075604821.44246819CS
      122.98541.8181818180.554.420.3691835700.75125863CS
      262.63292.2222222220.94.420.3691709230.83197623CS
      52-3.34-48.61717612816.877.20.36911304562.26963364CS
      156-65.02-94.850474106568.5572.60.3691102993332.5945107CS
      260-431.47-99.1885057471435503.250.3691112594141.73162672CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      ATPCAgape ATP Corporation
      $ 0.177
      (52.98%)
      		107.06M
      RDHLRedhill Biopharma Ltd
      $ 0.5869
      (52.80%)
      		182.79M
      DRMADermata Therapeutics Inc
      $ 2.51
      (45.93%)
      		5.26M
      BBLGBone Biologics Corporation
      $ 2.915
      (34.95%)
      		61.53M
      OMCLOmnicell Inc
      $ 37.2866
      (27.65%)
      		779.21k
      LABStandard BioTools Inc
      $ 1.345
      (-39.96%)
      		5.12M
      ALXOALX Oncology Holdings Inc
      $ 3.035
      (-36.77%)
      		5.55M
      VWEVintage Wine Estates Inc
      $ 0.0345
      (-33.53%)
      		27.22M
      MDJHMDJM Ltd
      $ 1.11
      (-31.06%)
      		5.17M
      NCNCnoco noco Inc
      $ 0.2153
      (-24.98%)
      		7.22M
      NVDANVIDIA Corporation
      $ 112.1574
      (-4.16%)
      		198.51M
      RDHLRedhill Biopharma Ltd
      $ 0.5869
      (52.80%)
      		182.79M
      SQQQProShares UltraPro Short QQQ
      $ 9.0533
      (5.39%)
      		133.38M
      ATPCAgape ATP Corporation
      $ 0.177
      (52.98%)
      		107.06M
      HUGEFSD Pharma Inc
      $ 0.1041
      (3.07%)
      		73.72M

      ALZN Discussion

      View Posts
      Roozy Roozy 2 days ago
      Told ya
      Ault has milked this dry so it’s bust!!
      👍️0
      Monksdream Monksdream 1 week ago
      ALZN new 52 week low
      👍️0
      Roozy Roozy 2 weeks ago
      They have no product
      👍️0
      PennyStockTrader2 PennyStockTrader2 2 weeks ago
      Maybe but I am trying to give benefit of doubt that he is distanced from ruining the company and I continue to accumulate at great prices in my opinion.
      👍️0
      Roozy Roozy 2 weeks ago
      This guy “Toddy” is a 1 man criminal enterprise destined for the greybar hotel.
      I go way back to his Prudential phase…
      👍️0
      Disquisition Disquisition 2 weeks ago
      A >99% loss in less than a year
      👍️0
      Roozy Roozy 2 weeks ago
      Worthless is worthless times 10
      Shut it down
      👍️0
      Roozy Roozy 3 weeks ago
      RS this Toddy
      👍️0
      Roozy Roozy 4 weeks ago
      Kisunla eh toddy?
      $33 ipo to $0!!!!
      👍️0
      Roozy Roozy 4 weeks ago
      Lilly rings the bell
      👍️0
      Roozy Roozy 1 month ago
      It’s a total fraud
      👍️0
      Monksdream Monksdream 1 month ago
      ALZN new 52 week low
      👍️0
      Roozy Roozy 1 month ago
      A total fraudulent lie company
      👍️0
      Monksdream Monksdream 1 month ago
      ALZN new 52 week low
      👍️0
      Roozy Roozy 1 month ago
      Lilly wins Toddy
      👍️0
      Roozy Roozy 3 months ago
      I have officially dumped this useless shit!
      👍️0
      Roozy Roozy 3 months ago
      If? That’s funny
      👍️0
      Roozy Roozy 3 months ago
      $33 to .50 true trash
      Ault’s history!!
      👍️0
      PennyStockTrader2 PennyStockTrader2 3 months ago
      bought in heavy volume all the way down to .48, the company is worth 3 million in the open market shares and a little less than half of those are locked up by insiders. IF they pull off what they are trying to do, look out. I miss the days of being able to write options on the stock as there are currently no options available and may not be offered in near to mid future, so now just need to buy cheap shares in volume
      👍️0
      Roozy Roozy 3 months ago
      HEY!!
      More baloney
      👍️0
      Roozy Roozy 3 months ago
      $33 to zip
      👍️0
      Lilman72003 Lilman72003 3 months ago
      intriguing.

      I like the chart here
      👍️0
      PennyStockTrader2 PennyStockTrader2 3 months ago
      yes but he is not running Alzamend, in fact he has helped finance it to avoid some more dilution. So while I dont disagree with what you're saying, including that his reputation could be affecting the share price, there could be other market forces at play.
      I'd like to see a move back toward 80 cents.
      👍️0
      Roozy Roozy 3 months ago
      Dreamer
      He is the cancer running through all his trash.
      Look at his ‘08 BK!! Cost us $240k!!
      👍️0
      PennyStockTrader2 PennyStockTrader2 3 months ago
      I actually do not believe its phony, and the dilution has been pretty minimal since inception. That said the direction is not good of the share price, I was a heavy buyer today. Insiders own over 40% of the company and nobody is selling. As long as Todd doesnt have his hands in running the company we should be ok.
      👍️0
      Roozy Roozy 3 months ago
      Another Phoney scam AULT Co!!!!!!
      👍️0
      Roozy Roozy 3 months ago
      Selling all shares @ .66
      👍️0
      Roozy Roozy 3 months ago
      Wey?
      👍️0
      Roozy Roozy 4 months ago
      Sell Now!!
      👍️0
      Roozy Roozy 4 months ago
      Welcome to Another AULT failure!!!$$
      👍️0
      Roozy Roozy 4 months ago
      Another rs!!??
      Screw aulty
      $33 ipo to $1 or less!!!!
      👍️0
      Monksdream Monksdream 4 months ago
      ALZN 10Q due 3/21
      👍️0
      Roozy Roozy 5 months ago
      🤞🏼
      👍️0
      Monksdream Monksdream 5 months ago
      ALZN 10Q due March 14
      👍️0
      Roozy Roozy 5 months ago
      The pump then the dump
      👍️0
      Roozy Roozy 6 months ago
      Another fake AULT stock
      IPO @ $33
      👍️0
      Monksdream Monksdream 6 months ago
      ALZN new 52=week low
      👍️0
      Roozy Roozy 6 months ago
      Why the “1” trades ?
      👍️0
      Roozy Roozy 7 months ago
      The AULT brand is poison!!!!!
      👍️0
      Roozy Roozy 8 months ago
      It’s the manipulation
      👍️0
      zagdad zagdad 8 months ago
      WTF...every time there is good news the pps seems to slide further...? Is it the AULT syndrome?
      👍️0
      Roozy Roozy 8 months ago
      And then the news!!!!
      Then the manipulation watch!!!!!
      👍️0
      Monksdream Monksdream 8 months ago
      ALZN new 52 week low
      👍️0
      Roozy Roozy 8 months ago
      Good news haha toilet dive
      👍️0
      Roozy Roozy 9 months ago
      Smoke and mirrors compliance
      An illusion
      👍️0
      Roozy Roozy 9 months ago
      Hooray more good news
      Aults lack of credibility means yawner
      👍️0
      Roozy Roozy 9 months ago
      Defined how?
      👍️0
      Disquisition Disquisition 9 months ago
      SAVAGE DUMPING
      👍️0
      Roozy Roozy 9 months ago
      Trash
      👍️0
      Roozy Roozy 9 months ago
      Another dishonest shell game to screw the shareholders. The SEC must nail this criminal manipulator.
      👍️0

      Your Recent History

      NASDAQ
      ALZN
      Alzamend Neuro
      Delayed Upgrade Clock